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Volume 53, Number 2 Abstracts 555“on-table” conversion to open surgical repair (2.8% vs 5.9%), the incidence
of nonfatal complications (37% vs 41%), and secondary interventions (26% vs
24%). Hd-unstable patients had a significantly higher incidence of develop-
ing abdominal compartment syndrome ([ACS] 29.4% vs 4.2%, P .05), and
death (Table). ACS had a significant impact on mortality (death with ACS:
62%; death without ACS: 11%, P  .05).
Conclusions: EVAR for r-AAA is feasible in both Hd-stable and
Hd-unstable patients. Hd-stable patients have a short-term and long-term
survival advantage, a lower incidence of ACS, and there is no difference in
the incidence for conversion to open surgical repair, nonfatal complications,
or the need for secondary interventions. Lowering the incidence of ACS
might have an impact on improving survival in Hd-unstable patients.
Table.
Variable Hd-stable Hd-unstable P
Mean AAA size, cm 6.4 6.6 NS
Preoperative CTA 70 (97.2%) 21 (61.8%) .05
ACS 3 (4.2%) 10 (29.4%) .05
30-day mortality 8 (9.7%) 11 (32.2%) .05
Survival at .05
1 year 88% 65%
2 years 79% 54%
3 years 71% 41%
Clinical Relevance of Serial CT Scans in Post-Endovascular Aneurysm
Repair Patients
Elizabeth L. Detschelt, MD,1 Victoria Y. Lee, MD,1 Joseph L. Grisafi,
MD,2 Marissa Toma,3 Daniel H. Benckart, MD,1 Satish C. Muluk, MD,1
1Allegheny General Hospital, Pittsburgh; 2Albert Einstein Medical Center,
Philadelphia; and 3Drexel University College of Medicine, Philadelphia, Pa.
Objective: This study examined the incidence of new clinically signif-
icant incidental (CSI) and endovascular aortic aneurysm repair (EVAR)-
related findings seen on CT scans during long-term follow-up to identify
demographic and clinical predictors of these findings.
Methods: We retrospectively reviewed 915 patients who underwent
EVAR at our institution between December 1, 1999, and November 30,
2009. A total of 608 patients who had an initial repair and had available
preoperative and postoperative CT scan reports defined the study popula-
tion. CSI and EVAR-related findings, demographic, and clinical variables
were recorded. Time course analysis of detection of new findings, and
univariate and multivariate analyses of predictors were performed.
Results: We reviewed 2965 CT scans. There was a median of four
(range, 2-16) CT scans and 32 months (range, 1-121 months) of follow-up
per patient. Overall detection of new CSI findings was 21%. Annual rate of
detection ranged from 14% to 32% over 9.5 years. Annual rate of detection
of EVAR-related findings ranged from 2% to 5% over the first 6 years and was
zero thereafter. Age65 years (P .024), glomerular filtration rate (GFR)
60 (P  .002), and body mass index 22 (P  .019) were predictors of
detecting new findings on univariate analysis. On multivariate analysis age
and GFR remained significant; tobacco use (P .015) was also a predictor.
No predictors were identified for EVAR -related findings.
Conclusions: NewCSI findings were detected at a constant rate on CT
scans obtained for post-EVAR follow-up over 10 years. EVAR-related
findings were detected at a constant rate up to 6 years after the procedure
and then were no longer detected. Patients with older age, renal impairment,
and tobacco use had more CSI findings. Our data suggest that (1) CT scan
may not be necessary for follow-up of EVAR patients after 6 years, and (2)
CT is more likely to detect a CSI finding that warrants further work-up than
a problem with the endograft. These findings are especially relevant as the
risks from repeated CT scans are being highlighted.
Single-Center Experience of Anticoagulation Therapy in Deep Venous
Thromboembolism Patients: Different Treatment Patterns?
Munier M. Nazzal, MD, Weikai Qu, MD, PhD, Mohamed Fedaly, MD,
Jihad Abbas, MD, Gerald Zelenock, MD, University of Toledo, School of
Medicine, Toledo, Ohio.
Objective: The optimal duration of anticoagulation therapy for deep
venous thromboembolism (DVT) is still under debate. The objective of our
study was to compare the outcome of anticoagulation treatment in DVT
patients by vascular surgeons (VS) and primary care physicians (PCP) and
analyze the underlying reasons that cause the differences.
Methods: Medical records of 485 DVT patients treated at our center
from 2000 to 2007 were retrospectively reviewed. Demographic data and
information about risk factors, site of DVT, length of anticoagulation
therapy, clot resolution rate monitored by ultrasound (US) imaging follow-
ups, and complications related to treatments were collected. Statistic analysis
E
cas conducted with SPSS 17.0 software. The 2 test or Fisher exact test was
sed for categoric data, and the Student t test was used for continuous data.
 .05 was considered statistically significant.
Results: Of the 485 patients, 122 were treated by VS and 363 were
reated by PCP. There were no significant differences in age, gender,
reexisting risk factors, and incidences of complications between two
roups. However, the VS group had a significantly higher US imaging
ollow-up rate (73% vs 47.1%, P  .0001), longer anticoagulation therapy
uration (P .03), and better clot resolution rate (P .009) than the PCP
roup (Table). Further analysis demonstrates a significant difference in the
ength of anticoagulation therapy between patients with or without US
enous tests. Forty-eight percent of patients without a US test received 3
onths treatment vs 52% patients with US test received  6 months of
nticoagulant treatment (P  .0001).
Conclusions: Venous US tests can provide valuable information dur-
ng the anticoagulation therapy in DVT patients. The optimal length of
nticoagulation treatment should be adjusted based on the US findings to
mprove the outcome of DVT management and avoid dangerous complica-
ions. The results in our study clearly show that VS use US follow-up in DVT
atients more than PCP and thus have better resolution rates of the clots and
onger period of Coumadin treatment.
able. Length of anticoagulation therapy and clot
esolution rate in different groups
Variable
Length of
anticoagulation
therapy (% of
patients)a
Clot resolution rate in US
follow-ups (% of patients)b
3
mon
3-6
mon
6
mon
No
change
Partial
resolution
Complete
resolution
ascular
surgeon
23.4 22.3 54.3 12.4 25.8 61.8
rimary care
physician
39.1 18.8 42.1 28.7 24.6 46.8
P  .03;
P  .009.
rocedural Factors Influencing the Incidence of Endovenous Heat-
nduced Thrombus (EHIT)
oo J. Rhee, MD, Julianne Stoughton, MD, Nancy L. Cantelmo, MD,
einSolutions, Stoneham, Mass.
Objectives: Endothermal ablation (ETA) has been shown to effectively
reat superficial venous reflux. Endothermal heat-induced thrombosis
EHIT) from the great saphenous vein (GSV) up to or into the common
emoral vein (CFV) has been reported as an early postprocedural complica-
ion of ETA. Our objective was to determine whether procedural factors
nfluence the incidence of EHIT.
Methods: From 2007 to 2009, 878 endothermal ablation procedures,
omprising 482 endovenous laser ablation (ELA), and 396 radiofrequency
blation (RFA), were performed in a single office practice to treat superficial
enous reflux. A retrospective review was performed of ultrasound images
nd patient records. Ultrasound images showing the position of the catheter
ip in relation to the saphenofemoral junction (SFJ) were available for 519
rocedures and were reviewed by independent evaluator. There were 234
LAs (45%) and 285 RFAs (55%). The distance between the tip of the
atheter and the SFJ was measured. Duplex ultrasound imaging was per-
ormed a mean of 2 days (range, 1-8 days) postprocedure.
Results: Of the 519 procedures, duplex ultrasound identified 21
4.0%) with extension of thrombus towards the femoral vein; of these 15
HITs occurred after ELA (6.4%) and 6 after RFA (2.1%; P  .02). There
as no difference in the mean (SD) distance of the catheter tip from the SFJ
etween the EHIT and non-EHIT groups (2.3 [0.5] cm, P  NS). The
ean (SD) diameter of the treated vein was similar (EHIT, 7.9 [2.3] mm,
on-EHIT, 7.8 [3.1] mm; P  NS). There was no difference in the EHIT
nd non-EHIT groups in concomitant thermal ablation of an additional
eins (14% vs 17%, P  NS), ambulatory phlebectomy (86% vs 90%, P 
S), or use of sclerotherapy of incompetent perforators and/or tributaries
19% vs 9%, P .13). The immediate postprocedure closure rate was 99.6%.
Conclusions: EHIT occurred more frequently after ELA than RFA.
here was no difference in catheter tip position or mean diameter of the
reated vein between the EHIT and non-EHIT groups. The concomitant
reatment of additional veins with ETA and/or microphlebectomy was
qual between the two groups. EHITs were found more commonly after
TA in combination with sclerotherapy, but this difference was not statisti-
ally significant.
